Oligonucleotide Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Synthesized Oligonucleotide Products, Reagents, Equipment, and Services), By Application (Research, Therapeutics, and Diagnostics), By End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospital and Diagnostic Laboratories), By
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationOligonucleotide Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Synthesized Oligonucleotide Products, Reagents, Equipment, and Services), By Application (Research, Therapeutics, and Diagnostics), By End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospital and Diagnostic Laboratories), By
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 4.03 Billion |
| CAGR (2023-2028) | 13.30% |
| Fastest Growing Segment | Therapeutics |
| Largest Market | North America |
Market Overview
Key Market Drivers
RNA-Based Therapeutics
Advancements in Genomic Research
Download free Sample Report
Key Market Challenges
Efficiency and Scalability
Cost Constraints
Key Market Trends
Therapeutic Advancements
Gene Editing and CRISPR-Cas9
Segmental Insights
Application
The Therapeutic Segment dominates the Oligonucleotide Synthesis market and is predicted to continue expanding over the coming years.
Download free Sample Report
Regional Insights
The North America region has established itself as the leader in the Oligonucleotide Synthesis Market in 2022.
Recent Developments
- July 2022WuXi STA, a subsidiary of WuXi AppTec, launched a newlarge-scale oligonucleotide and peptide manufacturing facility at its Changzhoucampus. This new launch enhances its capacity and capability to meet thefast-growing customer needs for oligonucleotide and peptide therapeuticsdevelopment and manufacturing worldwide.
- April 2022Bachem entered a strategic collaboration with Eli Lilly& Company to develop and manufacture active pharmaceutical ingredientsbased on oligonucleotides, a rising new class of complex molecules. Under theagreement, Bachem provides the appropriate engineering infrastructure andexpertise to implement Lilly’s novel oligonucleotide manufacturing technology.
Key Market Players
- Thermo FisherScientific Inc
- Agilent Technologies, Inc.
- Merck KGaA
- BIO-Synthesis Inc
- Eurofins Scientific SE
- Danaher Corporation
- Agilent Technologies, Inc.
- Biogen Inc.
- Ionis Pharmaceuticals, Inc.
- Sarepta Therapeutics, Inc.
| By Product Type | By Application | By End User | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy